ELI LILY (LLY) Q4 2024 earnings

Eli Lilly reported mixed results for the fourth quarter on Thursday, even when the demand for its great success of…

Novo Nordisk Ozempic wins FDA approval for chronic kidney disease

Food and medication administration approved Tuesday Novo Nordisk'S Ozempic to treat chronic kidney disease in patients who also have type…